Congenital glaucoma

Q17_CONGEN_GLAUC

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q15.0 Cause of death: ICD-10 — Q15.0 2 out of 7 registries used, show all original rules.	49
4. Check minimum number of events None	49
5. Include endpoints None	49
6. Filter based on genotype QC (FinnGen only)	39

Control definitions (FinnGen only)

Control exclude: Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF6v3

NAME	Q17_CONGEN_GLAUC
CONTROL_EXCLUDE	Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q150
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q150
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Congenital glaucoma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	427	189	235
Only index persons	351	158	193
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	20.21	29.94	11.72
Only index persons	23.28	30.94	17.01

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	39	21	18
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	46.60	45.13	48.31

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044889) 12 lead EKG panel

232

2.82

2.17

4.3

3.9

—

(40758558) Short blood count panel - Blood

132

2.37

1.98

4.3

6.2

—

(3010813) Leukocytes [#/volume] in Blood

386

+∞

1.62

25.5

26.6

6.52

6.81

e9/l

0.37

376

(3026361) Erythrocytes [#/volume] in Blood

386

+∞

1.62

25.5

26.4

4.49

e12/l

0.01

376

(3007461) Platelets [#/volume] in Blood

386

+∞

1.62

25.5

26.5

238.21

252.15

e9/l

0.73

379

(3007853) Bacteria identified in Skin by Aerobe culture

2.50

1.61

2.0

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.29

1.57

3.9

2.9

0.14

1.03

e6/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

3.62

1.57

1.2

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

300

2.67

1.49

21.6

22.1

331.51

333.45

g/l

0.57

300

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.23

1.43

4.0

3.2

7.13

2.35

e6/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2.09

1.39

3.9

3.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

148

2.00

1.36

6.3

3.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2.51

1.23

1.0

16.5

99.50

87.27

—

(40768797) Stomach Pathology biopsy report

2.16

1.16

1.0

1.2

—

(3018418) pH of Serum or Plasma

102

1.91

1.11

8.8

3.1

7.37

7.39

1.04

(3026008) Bacteria identified in Urine by Culture

112

1.86

1.06

2.5

2.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

168

1.79

1.03

8.6

10.1

1.23

1.22

mmol/l

0.65

159

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

319

2.14

1.02

4.5

5.2

1.80

2.04

mu/l

0.69

290

(36304419) Bacteria [Presence] in Urine

123

1.80

0.99

6.2

3.1

—

estimate

—

(40768804) Tissue Pathology biopsy report

125

1.76

0.93

1.6

2.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

144

1.73

0.91

2.3

1.9

84.28

93.88

pmol/l

0.49

(42870588) Differential panel, method unspecified - Blood

144

1.73

0.91

6.4

6.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

265

1.81

0.86

7.8

8.8

90.09

93.70

u/l

0.12

253

(3019225) pH of Specimen

0.00

0.80

0.0

8.1

—

7.38

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

104

1.68

0.76

2.9

4.3

24.93

33.19

u/l

1.97

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.89

0.76

3.7

3.5

—

(36660697) Celiac disease serology panel - Serum

1.70

0.69

1.0

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

123

0.57

0.68

4.1

5.8

3086.25

2081.58

ng/l

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

127

1.56

0.63

4.2

3.2

2.43

2.37

mmol/l

1.28

119

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.62

0.0

1.8

—

(3042936) Bacteria identified in Isolate by Culture

1.54

0.57

2.4

2.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

131

1.49

0.53

3.1

2.1

1.08

1.39

mmol/l

1.67

105

(3001122) Ferritin [Mass/volume] in Serum or Plasma

179

1.47

0.53

3.2

3.1

130.60

104.16

ug/l

0.25

169

(3000494) Fungus identified in Specimen by Culture

1.52

0.46

1.5

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1.52

0.46

1.8

1393.75

1199.96

nmol/l

—

(3023368) Bacteria identified in Blood by Culture

125

1.45

0.46

2.9

5.0

—

(3013512) EKG study

116

1.45

0.45

1.5

4.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.63

0.44

1.4

1.6

69.86

63.71

g/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

306

1.53

0.43

5.5

5.0

1.43

1.42

mmol/l

0.01

275

(3014051) Protein [Presence] in Urine by Test strip

108

1.44

0.42

3.2

2.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

0.00

0.42

0.0

2.1

—

118.70

—

(44806118) Parainfluenza type 4 nucleic acid detection

0.00

0.42

0.0

1.8

—

(44790048) Parainfluenza type 2 nucleic acid detection

0.00

0.42

0.0

1.8

—

(44790049) Parainfluenza type 3 nucleic acid detection

0.00

0.42

0.0

1.8

—

(44790047) Parainfluenza type 1 nucleic acid detection

0.00

0.42

0.0

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.43

0.42

10.6

9.2

0.98

1.21

mmol/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.41

0.0

1.3

—

(3008898) HLA-B27 [Presence]

0.00

0.41

0.0

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.41

0.0

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.41

0.0

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.41

0.41

1.9

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.41

0.0

2.5

—

0.00

—

(3015736) pH of Urine

157

1.38

0.39

4.3

3.5

6.50

6.22

0.50

(3018010) Neutrophils/Leukocytes in Blood

187

1.36

0.38

8.5

6.9

52.34

54.63

0.28

180

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.50

0.37

1.2

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.35

0.34

1.2

1.5

—

(3006504) Eosinophils/Leukocytes in Blood

189

1.34

0.34

7.0

3.84

3.01

1.00

177

(3027945) Reticulocytes/Erythrocytes in Blood

1.41

0.33

1.3

3.3

1.37

1.75

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

170

1.33

0.33

5.7

5.2

38.33

35.79

g/l

1.18

159

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

315

1.38

0.33

6.1

5.6

2.55

2.62

mmol/l

0.20

287

(3019069) Monocytes/Leukocytes in Blood

190

1.32

0.32

7.0

9.38

8.80

0.42

179

(3003694) ABO and Rh group [Type] in Blood

1.38

0.32

1.6

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.35

0.32

1.0

2.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.30

0.31

1.0

2.0

—

(1761868) Lipid panel - Serum or Plasma

126

0.73

0.29

3.8

3.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.26

0.29

5.5

10.2

0.70

0.81

mmol/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.29

0.28

1.0

2.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1.33

0.26

4.4

5.5

1.22

2.09

ug/l

0.73

(3002030) Lymphocytes/Leukocytes in Blood

194

1.27

0.26

7.3

6.9

30.27

29.53

0.07

184

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.21

0.0

3.4

—

3.79

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

3.87

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.21

0.0

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.21

0.0

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

0.00

0.21

0.0

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

358.92

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

0.21

0.0

3.5

—

(3027008) Opiates [Presence] in Urine

0.00

0.21

0.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.21

0.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

0.00

0.21

0.0

1.2

—

(3016879) Cocaine [Presence] in Urine

0.00

0.21

0.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

101

1.26

0.19

1.2

1.5

2.48

2.07

g/l

—

(3022096) Basophils/Leukocytes in Blood

189

1.22

0.19

7.7

6.9

0.84

0.69

1.00

178

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

190

1.21

0.17

5.5

7.9

23.47

19.98

umol/l

0.11

183

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.78

0.17

1.8

413.50

475.83

pmol/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1.18

0.17

7.3

5.2

—

(3032080) INR in Blood by Coagulation assay

161

1.20

0.16

19.8

16.3

1.48

1.29

inr

0.58

137

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.19

0.10

1.7

3.4

—

(3002256) Pathology report gross observation

1.15

0.10

1.0

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.10

0.10

1.4

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.80

0.09

2.4

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

0.83

0.08

1.3

3.9

351.14

353.34

umol/l

—

(3044640) Blood type and Crossmatch panel - Blood

119

1.13

0.07

1.8

3.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

251

0.90

0.06

2.9

3.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

100

1.13

0.06

1.7

1.5

24.64

22.38

nmol/l

0.18

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

148

0.92

0.03

3.9

32.89

45.18

ng/l

—

112

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

313

1.09

0.02

5.5

4.9

5.60

5.87

mmol/l

1.19

283

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

307

0.92

0.02

6.1

6.3

37.03

39.01

mmol/mol

0.96

282

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

106

0.93

0.01

4.0

2.7

71.20

55.20

u/l

—

100

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.01

0.00

1.7

2.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

295

1.06

0.00

4.4

4.2

1.11

1.15

mmol/l

0.21

262

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.0

1.7

—

0.54

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

3.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.9

—

31.94

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.02

0.00

2.4

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

0.86

-0.00

1.2

2.2

80.00

108.52

ug/g

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.3

—

2.67

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.5

—

6.62

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

7.0

—

78.20

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3011985) Renin [Units/volume] in Plasma

0.00

-0.00

0.0

2.0

—

36.54

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3044941) Cell count panel - Synovial fluid

0.00

-0.00

0.0

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

-0.00

0.0

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

-0.00

0.0

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

168.33

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.3

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.00

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

208.00

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

4.5

—

125.17

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

11.80

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

168.17

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.02

-0.00

2.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

1.49

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

30.82

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

150

1.00

-0.00

2.9

3.3

—

estimate

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

0.98

-0.00

9.8

14.6

25.20

25.06

mmol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

-0.00

0.0

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

6.0

—

8.05

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.3

—

88.67

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(40768800) Prostate Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_GLAUC and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_GLAUC.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_GLAUC – Congenital glaucoma

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Congenital glaucoma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints